Whan In Pharm Statistics

Total Valuation

Whan In Pharm has a market cap or net worth of KRW 175.72 billion. The enterprise value is 124.70 billion.

Market Cap	175.72B
Enterprise Value	124.70B

Important Dates

The last earnings date was Friday, February 14, 2025.

Earnings Date	Feb 14, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Whan In Pharm has 15.27 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	15.27M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	28.36%
Owned by Institutions (%)	18.90%
Float	10.94M

Valuation Ratios

The trailing PE ratio is 6.42 and the forward PE ratio is 8.70.

PE Ratio	6.42
Forward PE	8.70
PS Ratio	0.70
PB Ratio	0.47
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.49, with an EV/FCF ratio of -29.95.

EV / Earnings	4.56
EV / Sales	0.50
EV / EBITDA	3.49
EV / EBIT	4.48
EV / FCF	-29.95

Financial Position

The company has a current ratio of 4.54, with a Debt / Equity ratio of 0.00.

Current Ratio	4.54
Quick Ratio	3.01
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	-0.12
Interest Coverage	1,265.78

Financial Efficiency

Return on equity (ROE) is 7.55% and return on invested capital (ROIC) is 4.66%.

Return on Equity (ROE)	7.55%
Return on Assets (ROA)	4.15%
Return on Invested Capital (ROIC)	4.66%
Return on Capital Employed (ROCE)	7.13%
Revenue Per Employee	432.52M
Profits Per Employee	47.02M
Employee Count	582
Asset Turnover	0.62
Inventory Turnover	2.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.08% in the last 52 weeks. The beta is 0.20, so Whan In Pharm's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	-24.08%
50-Day Moving Average	11,839.00
200-Day Moving Average	13,335.05
Relative Strength Index (RSI)	36.38
Average Volume (20 Days)	12,936

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Whan In Pharm had revenue of KRW 251.73 billion and earned 27.36 billion in profits. Earnings per share was 1,792.00.

Revenue	251.73B
Gross Profit	96.27B
Operating Income	27.03B
Pretax Income	31.57B
Net Income	27.36B
EBITDA	34.91B
EBIT	27.03B
Earnings Per Share (EPS)	1,792.00

Full Income Statement

Balance Sheet

The company has 51.53 billion in cash and 506.64 million in debt, giving a net cash position of 51.02 billion or 3,342.09 per share.

Cash & Cash Equivalents	51.53B
Total Debt	506.64M
Net Cash	51.02B
Net Cash Per Share	3,342.09
Equity (Book Value)	374.16B
Book Value Per Share	24,507.41
Working Capital	155.20B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 31.28 billion and capital expenditures -35.44 billion, giving a free cash flow of -4.16 billion.

Operating Cash Flow	31.28B
Capital Expenditures	-35.44B
Free Cash Flow	-4.16B
FCF Per Share	-272.70

Full Cash Flow Statement

Margins

Gross margin is 38.24%, with operating and profit margins of 10.74% and 10.87%.

Gross Margin	38.24%
Operating Margin	10.74%
Pretax Margin	12.54%
Profit Margin	10.87%
EBITDA Margin	13.87%
EBIT Margin	10.74%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.61%.

Dividend Per Share	300.00
Dividend Yield	2.61%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	16.74%
Buyback Yield	n/a
Shareholder Yield	2.61%
Earnings Yield	15.57%
FCF Yield	-2.37%

Dividend Details

Stock Splits

The last stock split was on April 14, 2010. It was a forward split with a ratio of 2.

Last Split Date	Apr 14, 2010
Split Type	Forward
Split Ratio	2

Scores

Whan In Pharm has an Altman Z-Score of 5.11.

Altman Z-Score	5.11
Piotroski F-Score	n/a